Study Completed

CE in MR-Angiography, CE in MRI: CNS (adults), CE in MRI: CNS (children older than 6 years), CE in MRI: Liver, CE in MRI: kidneys

Bayer Identifier:

91798

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

2007-007121-40

EU CT Number:

Not Available

Gadovist: Effects of age and sex on PK after Gadovist inj.

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

Trial summary

Enrollment Goal

Trial Dates

August 2008 - January 2009

Phase

Phase 1

Could I Receive a placebo

N/A

Products

Gadavist/Gadovist (Gadobutrol, BAY86-4875)

Accepts Healthy Volunteer

N/A

Where to participate

Status	Institution	Location
Completed	Bayer Schering Pharma AG	Berlin, 13353, Germany

Trial design

Pharmacokinetics of gadobutrol after a single bolus intravenous 0.1 mmol/kg body weight dose of Gadovist injection in healthy elderly and non-elderly men and women

Trial Type

Interventional

Intervention Type

N/A

Trial Purpose

N/A

Allocation

N/A

Blinding

N/A

Assignment

N/A

Trial Arms

N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.